Mei Sheng Duh

Analysis Group, Inc., Boston, MA, USA

Poster(s):

• (C-038) Association of Hepatitis B Surface Antigen Loss (HBsAg) with Clinical Outcomes Among Patients with Chronic Hepatitis B Virus (HBV) Infection: A Retrospective Cohort Study in the United States (US)
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (B-213) Integrating the Patient Perspective Within Real-World Evidence: A Case Study Linking Routinely Collected Patient-Reported Outcomes and Electronic Health Records from Mass General Brigham Healthcare System
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (A-335) Leveraging Real-World Data for Regulatory Commitment: Methodological Considerations in a Post-Approval Safety Study Evaluating the Risk of Atrial Fibrillation (AF) Following Respiratory Syncytial Virus (RSV) Vaccination
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-121) Real-World Effectiveness of Ravulizumab in Adults With aHUS who Switched to Ravulizumab Within 3 Months of Eculizumab Treatment (aHUS IMPACT)
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET